Max Robotics — Global Service Robot Directory + US Certification

About

Yoshiyuki Kakehi is a leading figure in urologic oncology, with his research primarily centered on prostate cancer management, clinical guideline development, and the optimization of treatment strategies. His most impactful contribution is the authorship of the "Evidence-based clinical practice guideline for prostate cancer" (2017 edition) for the Japanese Urological Association, which has garnered 152 citations. This comprehensive work, covering epidemiology through palliative care, has become a cornerstone for standardizing prostate cancer care in Japan, reflecting his deep influence on clinical practice. Dr. Kakehi has also advanced the understanding of surgical safety, notably investigating the effects of steep Trendelenburg positioning during robotic-assisted laparoscopic prostatectomy on retinal structure and function, a critical patient safety concern. Furthermore, his work on the PRIAS-JAPAN study provides vital health-economic data, comparing medical costs of active surveillance versus other treatments for early prostate cancer. With a career dedicated to evidence-based urology, Dr. Kakehi’s research not only shapes national guidelines but also addresses practical, patient-centered outcomes, making him a key contributor to the field of prostate cancer research and clinical care.